View All Key Stats
NVAX Key Stats
| Income Statement | |
| Revenue (TTM) | 16.82M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.90 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -246.57M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -772.1% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 426.75M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 24.41 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -10.88 |
| Free Cash Flow (Quarterly) | -39.70M |
| Return on Equity (TTM) | -396.8% |
View All NVAX News
NVAX News
-
WireHeadlineTime (ET)
-
SA Breaking News07/19 09:14
-
Yahoo07/18 16:34
-
SA Breaking News07/18 12:52
-
Yahoo07/18 12:17
-
SA Breaking News07/18 11:00
-
SA Breaking News07/18 09:15
-
Yahoo07/18 08:00
-
SA Breaking News07/18 07:50
-
PR Newswire07/17 16:30
-
Yahoo07/12 08:00
View All Events
NVAX Events
| Date | Type | Description |
|---|---|---|
| 06/15/2017 08:30 EDT | Misc | Novavax Inc Annual General Meeting in 2016 |
| 05/08/2017 16:30 EDT | Misc | Novavax Inc First Quarter Earnings Conference Call in 2017 |
| 05/08/2017 | Earnings | Novavax Inc First Quarter Earnings in 2017 Release |
| 02/27/2017 16:30 EST | Misc | Novavax Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/27/2017 | Earnings | Novavax Inc Fourth Quarter Earnings in 2016 Release |
| 11/09/2016 16:30 EST | Misc | Novavax Inc Third Quarter Earnings Conference Call in 2016 |
| 11/09/2016 | Earnings | Novavax Inc Third Quarter Earnings in 2016 Release |
| 10/11/2016 | Misc | Novavax to Host 4th Annual Investor and Analyst Meeting |
| 10/07/2016 | Misc | Novavax Reschedules 4th Annual Investor and Analyst Meeting |
| 08/09/2016 04:30 EDT | Misc | Novavax Inc Second Quarter Earnings Conference Call in 2016 |
NVAX Fundamentals
Income Statement View Statement
NVAX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NVAX One Page Reports
- One Page Report Download
NVAX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 1.51 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.novavax.com
- Investor Relations URL: http://ir.novavax.com/phoenix.zhtml?c=71178&p=irol-irhome
- HQ State/Province: Maryland
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 08, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
NVAX Comparables
EditNVAX Excel Add-In Codes
- Name: =YCI("NVAX","name")
- Description: =YCI("NVAX","description")
- Sector: =YCI("NVAX","sector")
- Industry: =YCI("NVAX","industry")
- Est. Current Fiscal Year End: =YCI("NVAX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NVAX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVAX Tweets Stocktwits
Advertisement
